TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21661100

Group type: EXPERIMENTAL
Intervention: Aspart insulin protocol every 2 hours when BG > 200 mg/dL, and if admitted, began daily detemir in the ED
Number of subjects: 176

Group type: COMPARATOR
Intervention: Usual care (treated per hospital physicians)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Aspart insulin protocol
Number of subjects: 176

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 176
Study: 17983882

Group type: EXPERIMENTAL
Intervention: Operative group (reduction mammaplasty)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Nonoperative group
Number of subjects: 82
Study: 16926601

Group type: EXPERIMENTAL
Intervention: tacrolimus/mycophenolate mofetil (FK/MMF)
Number of subjects: 91

Group type: COMPARATOR
Intervention: cyclosporine/azathioprine (CSA/Aza)
Number of subjects: 91
Study: 14607455

Group type: EXPERIMENTAL
Intervention: LPS (20 IU/kg intravenously)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Vitamin C (24 mg/min)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 11087767

Group type: EXPERIMENTAL
Intervention: Haloperidol (mean dose, 1.8 mg/d)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Trazodone (mean dose, 200 mg/d)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Behavior Management Techniques (BMT)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 1836616

Group type: EXPERIMENTAL
Intervention: Tianeptine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 7084867

Group type: EXPERIMENTAL
Intervention: Irradiation therapy combined with vitamin A palmitate (1.5 mill. I.U./day; total dose: 30 mill. I.U.), applied orally
Number of subjects: 0

Group type: COMPARATOR
Intervention: Irradiation alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Irradiation therapy combined with vitamin A palmitate
Number of subjects: 0
Study: 30204741

Group type: EXPERIMENTAL
Intervention: Topical decolonization with nasal mupirocin and chlorhexidine body wash
Number of subjects: 1350

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 1350
Study: 30188971

Group type: EXPERIMENTAL
Intervention: GLIDE method for evaluating pleiotropy among genetic variants (SNPs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GLIDE method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Removal of potentially pleiotropic SNPs
Number of subjects: 0
Study: 26967008

Group type: EXPERIMENTAL
Intervention: Oral fluid intake after tonsillectomy (mean 18.2 mL/kg, SD 10.8 mL/kg)
Number of subjects: 473
Study: 25203377

Group type: EXPERIMENTAL
Intervention: Ligation of intersphincteric fistula track
Number of subjects: 70

Group type: COMPARATOR
Intervention: Mucosal advancement flap
Number of subjects: 70
Study: 22794154

Group type: EXPERIMENTAL
Intervention: Test formulation of clozapine (100 mg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Reference formulation of clozapine (100 mg)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both test and reference formulations of clozapine
Number of subjects: 26
Study: 20728210

Group type: EXPERIMENTAL
Intervention: Trastuzumab plus chemotherapy
Number of subjects: 594

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 594
Study: 17664517

Group type: EXPERIMENTAL
Intervention: Usual care plus telephone monitoring and care management
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Usual care plus care management plus peer-led chronic-disease self-management group
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Usual care plus care management plus professionally led depression psychotherapy group
Number of subjects: 104

Group type: COMPARATOR
Intervention: Usual behavioral health care
Number of subjects: 104
Study: 16362506

Group type: EXPERIMENTAL
Intervention: Salivary volume
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Salivary volume/salivary pH
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Salivary volume and salivary pH x volume
Number of subjects: 39
Study: 11886002

Group type: EXPERIMENTAL
Intervention: Treosulfan 7 g/m2 infused over 30 min, repeated every 4 weeks
Number of subjects: 78

Group type: COMPARATOR
Intervention: Leuprorelin 3.75 mg injected subcutaneously or intramuscularly, repeated every 4 weeks
Number of subjects: 78
Study: 10082251

Group type: EXPERIMENTAL
Intervention: Antiepilepsirine (AES) 10 mg/kg per day
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 7676784

Group type: EXPERIMENTAL
Intervention: enflurane 0.3% - nitrous oxide
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: enflurane 0.6% - nitrous oxide
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: enflurane 0.9% - nitrous oxide
Number of subjects: 40

Group type: COMPARATOR
Intervention: control (fentanyl-nitrous oxide anaesthesia)
Number of subjects: 40
Study: 2308759

Group type: EXPERIMENTAL
Intervention: Benzydamine 3% cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6349650

Group type: EXPERIMENTAL
Intervention: Meclofenamate sodium (300 mg per day for a maximum of 3 weeks)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Indomethacin (150 mg per day)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Meclofenamate sodium
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 161
Study: 31232675

Group type: EXPERIMENTAL
Intervention: Body acceptance intervention
Number of subjects: 19
Study: 30872176

Group type: EXPERIMENTAL
Intervention: Technique protecting blood supply to the superior parathyroid
Number of subjects: 113

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 113
Study: 29458842

Group type: EXPERIMENTAL
Intervention: Fish Oil (FO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blueberry (BB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined FO + BB
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26731485

Group type: EXPERIMENTAL
Intervention: Food allergen challenge
Number of subjects: 362

Group type: COMPARATOR
Intervention: Placebo challenge
Number of subjects: 362
Study: 24577287

Group type: EXPERIMENTAL
Intervention: CBT4CBT
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard methadone maintenance
Number of subjects: 101
Study: 24343688

Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure of 10 cmH2O (Group C)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure of 8 cmH2O (Group B)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure of 5 cmH2O (Group A)
Number of subjects: 136
Study: 20129212

Group type: EXPERIMENTAL
Intervention: Fosinopril (6 months)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Placebo (6 months)
Number of subjects: 257
Study: 18196446

Group type: EXPERIMENTAL
Intervention: Structured early consultation with the occupational physician (OP)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Care as usual (Control)
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Structured early consultation with the OP
Number of subjects: 299
Study: 16225558

Group type: EXPERIMENTAL
Intervention: Psychoeducation
Number of subjects: 93

Group type: COMPARATOR
Intervention: Non-psychoeducation (Control)
Number of subjects: 93
Study: 12797942

Group type: EXPERIMENTAL
Intervention: Antimicrobial filter (used in phase 1)
Number of subjects: 65

Group type: COMPARATOR
Intervention: No antimicrobial filter (used in phase 2)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Recommendations of SEPAR for disinfecting lung function equipment
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Antimicrobial filter
Number of subjects: 65
Study: 10567956

Group type: EXPERIMENTAL
Intervention: Basiliximab (20 mg injections, one prior to surgery and one on Day 4 posttransplant)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Simulation method for prediction
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: First-order approximation methods (inverse regression and inversion of confidence intervals)
Number of subjects: 39
Study: 8671319

Group type: EXPERIMENTAL
Intervention: 75 microgram dose of desogestrel
Number of subjects: 44

Group type: COMPARATOR
Intervention: 30 microgram dose of desogestrel
Number of subjects: 44

Group type: COMPARATOR
Intervention: 50 microgram dose of desogestrel
Number of subjects: 44
Study: 1751794

Group type: EXPERIMENTAL
Intervention: Epoetin (100 to 150 U/kg)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Epoetin (25 U/kg)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Epoetin (100 U/kg)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Epoetin (200 U/kg)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Epoetin (all doses combined)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy
Number of subjects: 151
Study: 6753888

Group type: EXPERIMENTAL
Intervention: Oral disopyramide phosphate (loading dose of 150, 200, or 300 mg followed by maintenance doses of 100, 150, or 200 mg every 6 hours based on weight)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Oral disopyramide phosphate
Number of subjects: 101
Study: 31207334

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 27844152

Group type: EXPERIMENTAL
Intervention: Clinician-directed therapy (n = 26)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: SwallowIT-assisted therapy (n = 26)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Patient-directed therapy (n = 27)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: All groups (n = 79)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Baseline factors
Number of subjects: 79
Study: 24593317

Group type: EXPERIMENTAL
Intervention: Alcohol-free essential oil mouthwash (AF-EOMW) used twice a day
Number of subjects: 25

Group type: COMPARATOR
Intervention: Tap water (control)
Number of subjects: 25
Study: 25588917

Group type: EXPERIMENTAL
Intervention: Tailored education, doctor's reminder, and cost reduction
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Cost reduction
Number of subjects: 448

Group type: COMPARATOR
Intervention: Other intervention arms (without cost reduction)
Number of subjects: 448
Study: 21380536

Group type: EXPERIMENTAL
Intervention: Low-level laser treatment (630-670 nm, 1.875 J/cm²) plus scaling and root planing (SRP) for five consecutive days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low-level laser treatment (630-670 nm, 1.875 J/cm²) plus scaling and root planing (SRP) for ten consecutive days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) on a single quadrant/day for four consecutive days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no periodontal disease)
Number of subjects: 60
Study: 19056656

Group type: COMPARATOR
Intervention: Control spread (n = 87)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Spread with plant sterol esters (1.1 g/d or 2.2 g/d plant sterols; n = 120)
Number of subjects: 217
Study: 17888974

Group type: EXPERIMENTAL
Intervention: CorCap Cardiac Support Device (CSD) with mitral surgery
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: CorCap Cardiac Support Device (CSD)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (mitral surgery alone or medical therapy)
Number of subjects: 300
Study: 15002024

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% in the evening (2000 hours)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Timolol 0.5% twice daily (0800 and 2000 hours)
Number of subjects: 103
Study: 11696289

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori eradication
Number of subjects: 0
Study: 9702915

Group type: EXPERIMENTAL
Intervention: DHA (0.35% of total fatty acids)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: DHA (0.36%) and AA (0.72%)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Unsupplemented infants
Number of subjects: 108

Group type: COMPARATOR
Intervention: All diet groups
Number of subjects: 108
Study: 8011964

Group type: EXPERIMENTAL
Intervention: Caplet formulation (product A)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Tablet formulation (product B)
Number of subjects: 14
Study: 2637335

Group type: EXPERIMENTAL
Intervention: Hand instrumentation with K-Flex files
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Sonic instrumentation with the Endostar 5
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Sonic instrumentation with the Sonic Air MM 3000
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Ultrasonic instrumentation with the Cavi-Endo unit
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 105
Study: 770150

Group type: EXPERIMENTAL
Intervention: Clomipramine plus Lithium Carbonate
Number of subjects: 30

Group type: COMPARATOR
Intervention: Clomipramine plus placebo
Number of subjects: 30
Study: 31205190

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study: 28800765

Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil administered preoperatively (n=16)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil administered post-MTS (n=14)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (n=15)
Number of subjects: 45
Study: 24612471

Group type: EXPERIMENTAL
Intervention: Hands-on Surgical Training (HoST) technology group
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study: 22397878

Group type: EXPERIMENTAL
Intervention: Low-CHO/high-monounsaturated-fat diet (M)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: High-CHO/low-GI diet (L)
Number of subjects: 104

Group type: COMPARATOR
Intervention: High-CHO/high-GI diet (H)
Number of subjects: 104
Study: 21335122

Group type: EXPERIMENTAL
Intervention: Mediastinal lymph node sampling
Number of subjects: 1023

Group type: COMPARATOR
Intervention: Mediastinal lymph node dissection
Number of subjects: 1023
Study: 18093792

Group type: EXPERIMENTAL
Intervention: Hypertensive patients
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Hypertensive patients with a history of myocardial infarction or stroke
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 100
Study: 16002439

Group type: EXPERIMENTAL
Intervention: Electrical stimulation of vestibular nerves to evoke virtual head rotation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Model based on vector operations and anatomy of semicircular canals
Number of subjects: 0
Study: 12538184

Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Bupivacaine dorsal penile nerve block
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 63

Group type: COMPARATOR
Intervention: Sodium chloride solution dorsal penile block
Number of subjects: 63
Study: 10775890

Group type: EXPERIMENTAL
Intervention: TRY- (low tryptophan diet with amino acid mixture without tryptophan)
Number of subjects: 30

Group type: COMPARATOR
Intervention: TRY+ (normal tryptophan diet with amino acid mixture with tryptophan)
Number of subjects: 30
Study: 8803517

Group type: EXPERIMENTAL
Intervention: FK-224 (2 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13

Group type: COMPARATOR
Intervention: Saline plus ethanol (diluent for BK)
Number of subjects: 13
Study: 1611544

Group type: EXPERIMENTAL
Intervention: tyrosine-adsorbed Dermatophagoides pteronyssinus vaccine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: prolonged hyposensitization
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study: 6361299

Group type: EXPERIMENTAL
Intervention: Cholestyramine resin
Number of subjects: 3806

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3806
Study: 31422722

Group type: EXPERIMENTAL
Intervention: Support-training system of peer group, 8 training sessions over 4 months
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 112
Study: 29258367

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg daily for 6 months
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 200
Study: 25130052

Group type: EXPERIMENTAL
Intervention: Oxymorphone (10, 20, and 40 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Oxymorphone (40 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Oxycodone (10, 20, and 40 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 24800725

Group type: EXPERIMENTAL
Intervention: Pasireotide LAR 20 mg/month
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Pasireotide LAR 40 mg/month
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Pasireotide LAR 60 mg/month
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Pasireotide LAR (all doses)
Number of subjects: 35
Study: 22177176

Group type: EXPERIMENTAL
Intervention: Simulator training (Group 1)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No training (Group 2)
Number of subjects: 24
Study: 20037150

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 120

Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sevoflurane with BMI >=30 kg/m²
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sevoflurane MAC-hour
Number of subjects: 120

Group type: COMPARATOR
Intervention: Desflurane MAC-hour
Number of subjects: 120
Study: 26606967

Group type: EXPERIMENTAL
Intervention: T-DM1 and anti-CTLA-4/PD-1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Depletion of regulatory T cells
Number of subjects: 0
Study: 12752916

Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment (ART)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Amalgam restorations
Number of subjects: 35
Study: 10699346

Group type: EXPERIMENTAL
Intervention: Pseudomonas aeruginosa OMPs vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Post-immune sera of burn patients
Number of subjects: 0
Study: 9356538

Group type: EXPERIMENTAL
Intervention: Low-protein diet (0.7 g/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Medium-protein diet (1.0 g/kg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High-protein diet (2.1 g/kg)
Number of subjects: 16
Study: 8403156

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl 25 micrograms
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl 50 micrograms
Number of subjects: 50
Study: 3780124

Group type: EXPERIMENTAL
Intervention: Diazepam (0.15 and 0.30 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Buspirone (15 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Buspirone + Diazepam (0.30 mg/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Diazepam (0.30 mg/kg)
Number of subjects: 12
Study: 30074996

Group type: EXPERIMENTAL
Intervention: Individually-tailored multifactorial intervention
Number of subjects: 268

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 268
Study: 26815250

Group type: EXPERIMENTAL
Intervention: Isometric exercise of the glenohumeral external rotators
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emotional stress task (watching 'unpleasant' images)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physical testing procedure
Number of subjects: 0
Study: 25266547

Group type: EXPERIMENTAL
Intervention: Aripiprazole lauroxil 441 mg IM in the deltoid
Number of subjects: 46

Group type: COMPARATOR
Intervention: Aripiprazole lauroxil 441 mg IM in the gluteal
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Aripiprazole lauroxil 441 mg IM in the deltoid or gluteal
Number of subjects: 46
Study: 22382362

Group type: EXPERIMENTAL
Intervention: Ipilimumab 3 or 10 mg/kg every 3 weeks for four doses followed by maintenance dosing
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Ipilimumab treatment
Number of subjects: 82
Study: 20067654

Group type: EXPERIMENTAL
Intervention: Surgical or catheter interventional treatment of coarctation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 14
Study: 18837100

Group type: EXPERIMENTAL
Intervention: Clear liquid diet and overnight fast
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Purgative preparation
Number of subjects: 0
Study: 16428147

Group type: EXPERIMENTAL
Intervention: Silicic acid applied twice daily for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo applied twice daily for 8 weeks
Number of subjects: 40
Study: 12588272

Group type: EXPERIMENTAL
Intervention: Multifaceted community booster seat campaign
Number of subjects: 3609

Group type: COMPARATOR
Intervention: Control communities (no intervention)
Number of subjects: 3609
Study: 10229307

Group type: EXPERIMENTAL
Intervention: Screening based on maternal risk factors
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 75 g oral glucose tolerance test (OGTT)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Combined diabetic antenatal clinic
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Written guidelines for screening
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: National guidelines for screening
Number of subjects: 84
Study: 8902442

Group type: EXPERIMENTAL
Intervention: 3 mg/day E2 cream continuously for 12 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 40
Study: 1906893

Group type: EXPERIMENTAL
Intervention: Oral estradiol administration
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol administration
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Both treatments (oral and transdermal)
Number of subjects: 5
Study: 6347315

Group type: EXPERIMENTAL
Intervention: Truncal vagotomy with graded pyloric dilatation (TV + PD)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Truncal vagotomy with pyloroplasty (TV + P)
Number of subjects: 41
Study: 29335827

Group type: EXPERIMENTAL
Intervention: O‐SES (ultrathin strut biodegradable polymer sirolimus‐eluting stent)
Number of subjects: 4
Study: 28225648

Group type: EXPERIMENTAL
Intervention: Autologous human Schwann cell transplantation
Number of subjects: 6
Study: 26200798

Group type: EXPERIMENTAL
Intervention: Take Control Course (TCC)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (individual low-intensity interventions)
Number of subjects: 109